🔴 HCW Biologics is trading 5% down in pre-market with no clear catalyst identified

HCW Biologics is trading at $1.73, down 5.04%, with no clear catalyst identified for the September 29 pre-market decline.

• No new company-specific announcement explaining the decline was identified; the latest company release, on September 24, announced a $1.5 million private placement.
• HCW Biologics fell 5.70% in the September 28 regular session and 5.5% after hours. Mixed market indicators do not establish a broad-market explanation; continued selling is possible, but the cause remains uncertain.